CA2719070A1 - Substituted piperidines as therapeutic compounds - Google Patents

Substituted piperidines as therapeutic compounds Download PDF

Info

Publication number
CA2719070A1
CA2719070A1 CA2719070A CA2719070A CA2719070A1 CA 2719070 A1 CA2719070 A1 CA 2719070A1 CA 2719070 A CA2719070 A CA 2719070A CA 2719070 A CA2719070 A CA 2719070A CA 2719070 A1 CA2719070 A1 CA 2719070A1
Authority
CA
Canada
Prior art keywords
straight
chain
methyl
acid
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2719070A
Other languages
English (en)
French (fr)
Inventor
Peter Herold
Robert Mah
Stefan Stutz
Vincenzo Tschinke
Aleksandar Stojanovic
Dirk Behnke
Stjepan Jelakovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA2719070A1 publication Critical patent/CA2719070A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA2719070A 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds Abandoned CA2719070A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08153929 2008-04-02
EP08153929.8 2008-04-02
PCT/EP2009/053898 WO2009121914A1 (en) 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds

Publications (1)

Publication Number Publication Date
CA2719070A1 true CA2719070A1 (en) 2009-10-08

Family

ID=40627638

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2719070A Abandoned CA2719070A1 (en) 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds

Country Status (10)

Country Link
EP (1) EP2271644A1 (pt)
JP (1) JP2011516453A (pt)
KR (1) KR20110002459A (pt)
CN (1) CN101970431A (pt)
AU (1) AU2009232012A1 (pt)
BR (1) BRPI0910991A2 (pt)
CA (1) CA2719070A1 (pt)
EA (1) EA201001517A1 (pt)
MX (1) MX2010010876A (pt)
WO (1) WO2009121914A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057160A2 (en) * 2009-11-06 2011-05-12 The Regents Of The Uiversity Of California Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
CN102638981B (zh) 2009-10-14 2015-07-22 默沙东公司 提高p53活性的取代的哌啶和其用途
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds
US8987274B2 (en) 2011-10-28 2015-03-24 Merck Sharp & Dohme Corp Macrocycles that increase p53 activity and the uses thereof
TW201429969A (zh) 2012-12-20 2014-08-01 Merck Sharp & Dohme 作爲ｈｄｍ２抑制劑之經取代咪唑吡啶
CN105001300A (zh) * 2014-04-17 2015-10-28 复旦大学 组织蛋白酶d抑制剂及其制备方法、药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
EP1911758A1 (en) * 2006-10-04 2008-04-16 Speedel Experimenta AG Phenyl piperidine derivatives for use as renin inhibitors
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds

Also Published As

Publication number Publication date
EA201001517A1 (ru) 2011-04-29
AU2009232012A1 (en) 2009-10-08
CN101970431A (zh) 2011-02-09
KR20110002459A (ko) 2011-01-07
BRPI0910991A2 (pt) 2016-01-19
EP2271644A1 (en) 2011-01-12
MX2010010876A (es) 2010-10-26
WO2009121914A1 (en) 2009-10-08
JP2011516453A (ja) 2011-05-26

Similar Documents

Publication Publication Date Title
US20070066582A1 (en) Diaminoalcohols as therapeutic compounds
US20070021413A1 (en) Diamino alcohols as therapeutic compounds
CA2719070A1 (en) Substituted piperidines as therapeutic compounds
US8153658B2 (en) Piperidine derivative or salt thereof
US20070167433A1 (en) 3,4,5-Substituted piperidines as therapeutic compounds
JP7319395B2 (ja) Ｓａｒｍ１の阻害剤
AU2021333558B2 (en) Inhibitors of SARM1
CA3123215A1 (en) Inhibitors of sarm1 in combination with neuroprotective agents
EP1958666A1 (en) Heterocyclic-substituted alkanamides as therapeutic compounds
US20070021400A1 (en) Amino alcohols as therapeutic compounds
WO2009106599A2 (en) Substituted piperidines as therapeutic compounds
EP1867329A2 (en) 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds
US20070021399A1 (en) Amido-amino alcohols as therapeutic compounds
EP1987834A2 (en) Substituted piperidines as therapeutic compounds
US20070066604A1 (en) Diaminoalcohols as therapeutic compounds
US20240051939A1 (en) Benzopyrazole inhibitors of sarm1
TW202304888A (zh) 醚連接之抗病毒化合物
EP1872780A2 (en) Omega-Phenyloctanamides as therapeutic compounds
CA3174321A1 (en) Indazole derivatives as inhibitors of sarm1
JP7477642B2 (ja) Ｓａｒｍ１の阻害剤
JP7490781B2 (ja) Ｓａｒｍ１の阻害剤
EP1958634A2 (en) Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
EP2018862A1 (en) Substituted piperidines as therapeutic compounds
WO2021050913A1 (en) Inhibitors of sarm1
CN116940569A (zh) Sarm1抑制剂

Legal Events

Date Code Title Description
FZDE Dead